Physicochemical properties and drug-release mechanisms of dual-release bilayer tablet containing mirabegron and fesoterodine fumarate

References

• Chapple, CR, Nazir J, Hakimi Z. et al. Persistence and adherence with mirabegron versus antimuscarinic agents in patients with overactive bladder: a retrospective observational study in UK clinical practice. Eur Urol. 2017;72(3):389–399. doi:10.1016/j.eururo.2017.01.03728196724
   PubMed Web of Science ®Google Scholar
• Abrams, P., Kelleher C, Staskin D. et al. Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony). Eur Urol. 2015;67(3):577–588. doi:10.1016/j.eururo.2014.02.01224612659
   PubMed Web of Science ®Google Scholar
• Kadekawa, K., Sugaya K, Nishijima S. et al. Effects of combination treatment with fesoterodine and mirabegron on urinary bladder functions of pelvic congestion model in rats. in neurourology and urodynamics. 111 River St, Hoboken 07030-5774, NJ, USA: Wiley-Blackwell; 2016.
   Google Scholar
• Michel MC. Fesoterodine: a novel muscarinic receptor antagonist for the treatment of overactive bladder syndrome. Expert Opin Pharmacother. 2008;9(10):1787–1796. doi:10.1517/14656566.9.10.178718570610
   PubMed Web of Science ®Google Scholar
• Matsuzaki N, Yamamoto Y, Murayama D, et al. Evaluation of maltose-induced chemical degradation at the interface of bilayer tablets. Chem Pharm Bulletin. 2017;65(5):478–486. doi:10.1248/cpb.c16-00929
   PubMed Web of Science ®Google Scholar
• Abebe A, Akseli I, Sprockel O, Kottala N, Cuitiño AM. Review of bilayer tablet technology. Int J Pharm. 2014;461(1–2):549–558. doi:10.1016/j.ijpharm.2013.12.02824370841
   PubMed Web of Science ®Google Scholar
• Panchal HA, Tiwari AK. A novel approach of bilayer tablet technology: a review. Int Res J Pharm. 2012;3(5):44–49.
   Google Scholar
• Chapple C, Van Kerrebroeck P, Tubaro A, et al. Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder. Eur Urol. 2007;52(4):1204–1212. doi:10.1016/j.eururo.2007.07.00917651893
   PubMed Web of Science ®Google Scholar
• Chapple CR, Kaplan SA, Mitcheson D, et al. Mirabegron 50 mg once‐daily for the treatment of symptoms of overactive bladder: an overview of efficacy and tolerability over 12 weeks and 1 year. Int J Urol. 2014;21(10):960–967. doi:10.1111/iju.1256825092441
   PubMed Web of Science ®Google Scholar
• Göpferich A. Polymer bulk erosion. Macromolecules. 1997;30(9):2598–2604. doi:10.1021/ma961627y
   Web of Science ®Google Scholar
• Bose A, Wong TW, Singh N. Formulation development and optimization of sustained release matrix tablet of Itopride HCl by response surface methodology and its evaluation of release kinetics. Saudi Pharm J. 2013;21(2):201–213. doi:10.1016/j.jsps.2012.03.00623960836
   PubMed Web of Science ®Google Scholar
• Bagde, SB, Bakde BV, Channawar MA, Chandewar AV. Formulation and evaluation of bi layer tablet of metoprolol succinate and Ramipril. Int J Pharm Pharm Res. 2011;6:1416–1428.
   Google Scholar
• Van Nguyen H, Nguyen VH, Lee B-J. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture. Int J Pharm. 2016;515(1–2):233–244. doi:10.1016/j.ijpharm.2016.10.02127744034
   PubMed Web of Science ®Google Scholar
• Jun, H, Lee HJ, Shin BS, Park CW. Preparation and in vivo characterization of dual release tablet containing sarpogrelate hydrochloride. J Pharm Invest. 2018;48(3):363–372. doi:10.1007/s40005-017-0330-z
   Google Scholar
• Coffel J, Gandhi S, Nuxoll E. Unified polymer erosion model for pulsatile drug delivery. J Memb Sci. 2016;512:61–72. doi:10.1016/j.memsci.2016.03.055
   Web of Science ®Google Scholar
• Kazarian SG, Chan KA. “Chemical photography” of drug release. Macromolecules. 2003;36(26):9866–9872. doi:10.1021/ma035210l
   Web of Science ®Google Scholar
• Ribar T, Bhargava R, Koenig JL. FT-IR imaging of polymer dissolution by solvent mixtures. 1. Solvents. Macromolecules. 2000;33(23):8842–8849. doi:10.1021/ma000851r
   Web of Science ®Google Scholar
• Coutts-Lendon C, Wright NA, Mieso EV, Koenig JL. The use of FT-IR imaging as an analytical tool for the characterization of drug delivery systems. J Control Release. 2003;93(3):223–248.14644574
   PubMed Web of Science ®Google Scholar
• van der Weerd J, Chan KA, Kazarian SG. An innovative design of compaction cell for in situ FT-IR imaging of tablet dissolution. Vib Spectrosc. 2004;35(1–2):9–13. doi:10.1016/j.vibspec.2003.11.004
   Web of Science ®Google Scholar
• Hashem FM, Nasr M, Fathy G, Ismail A. Formulation and in vitro and in vivo evaluation of lipid-based terbutaline sulphate bi-layer tablets for once-daily administration. AAPS PharmSciTech. 2016;17(3):727–734. doi:10.1208/s12249-015-0404-z26335420
   PubMed Web of Science ®Google Scholar
• Tambe ST,, Padekar HB, Dhobale SM, Jadhav SL. Design and characterisation of bi-layer tablets containing simvastatin as sustained release and labetalol HCl as immediate release. J Drug Deliv Ther. 2019;9(2 Suppl):263–270.
   Google Scholar
• Aryal S, Škalko-Basnet N. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types. Acta Pharmaceutica. 2008;58(3):299–308. doi:10.2478/v10007-008-0012-519103566
   PubMed Web of Science ®Google Scholar
• Vaithiyalingam SR, Sayeed VA. Critical factors in manufacturing multi-layer tablets—assessing material attributes, in-process controls, manufacturing process and product performance. Int J Pharm. 2010;398(1–2):9–13. doi:10.1016/j.ijpharm.2010.07.02520656000
   PubMed Web of Science ®Google Scholar
• Gurny R, Doelker E, Peppas N. Modelling of sustained release of water-soluble drugs from porous, hydrophobic polymers. Biomaterials. 1982;3(1):27–32.7066463
   PubMed Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52(12):1145–1149.14088963
   PubMed Web of Science ®Google Scholar
• Hixson A, Crowell J. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem. 1931;23(8):923–931. doi:10.1021/ie50260a018
   Google Scholar
• Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for controlled drug release. Chem Rev. 1999;99(11):3181–3198.11749514
   PubMed Web of Science ®Google Scholar
• Lamoudi L, Chaumeil JC, Daoud K. Swelling, erosion and drug release characteristics of sodium diclofenac from heterogeneous matrix tablets. J Drug Delivery Sci Technol. 2016;31:93–100. doi:10.1016/j.jddst.2015.12.005
   Web of Science ®Google Scholar
• Nep E, Asare-Addo K, Ghori MU, Conway BR, Smith AM. Starch-free grewia gum matrices: compaction, swelling, erosion and drug release behaviour. Int J Pharm. 2015;496(2):689–698. doi:10.1016/j.ijpharm.2015.10.07126536530
   PubMed Web of Science ®Google Scholar
• Chaibva FA, Khamanga SM, Walker RB. Swelling, erosion and drug release characteristics of salbutamol sulfate from hydroxypropyl methylcellulose-based matrix tablets. Drug Dev Ind Pharm. 2010;36(12):1497–1510. doi:10.3109/03639045.2010.48864820528615
   PubMed Web of Science ®Google Scholar
• Sriamornsak P, Thirawong N, Weerapol Y, Nunthanid J, Sungthongjeen S. Swelling and erosion of pectin matrix tablets and their impact on drug release behavior. Eur J Pharm Biopharm. 2007;67(1):211–219. doi:10.1016/j.ejpb.2006.12.01417267193
   PubMed Web of Science ®Google Scholar
• Yadav D, Survase S, Kumar N. Dual coating of swellable and rupturable polymers on Glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation. Int J Pharm. 2011;419(1–2):121–130. doi:10.1016/j.ijpharm.2011.07.02621807081
   PubMed Web of Science ®Google Scholar
• Punčochová K, Ewing AV, Gajdošová M, et al. Identifying the mechanisms of drug release from amorphous solid dispersions using MRI and ATR-FTIR spectroscopic imaging. Int J Pharm. 2015;483(1–2):256–267. doi:10.1016/j.ijpharm.2015.02.03525686660
   PubMed Web of Science ®Google Scholar
• Hifumi H, Ewing AV, Kazarian SG. ATR-FTIR spectroscopic imaging to study the drying and dissolution of pharmaceutical polymer-based films. Int J Pharm. 2016;515(1–2):57–68. doi:10.1016/j.ijpharm.2016.09.08527720876
   PubMed Web of Science ®Google Scholar
• Grassi M, Grassi G. Mathematical modelling and controlled drug delivery: matrix systems. Curr Drug Deliv. 2005;2(1):97–116.16305412
   PubMedGoogle Scholar
• Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217–223.20524422
   PubMed Web of Science ®Google Scholar
• Chen S, Zhu J, Cheng J. Preparation and in vitro evaluation of a novel combined multiparticulate delayed-onset sustained-release formulation of diltiazem hydrochloride. Die Pharmazie-An Int J Pharm Sci. 2007;62(12):907–913.
   Google Scholar